Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 62 for “"Hematologic malignancy"”.

  1. Mechanisms of ETV6 Mislocalization in Familial Thrombocytopenia and Hematologic Malignancy

    … in families with inherited thrombocytopenia and hematologic malignancy. Nearly all of the described missense mutations are localized to the C-terminal ETS DNA-binding domain (DBD), with the lone exception being a Pro214Leu (P214L) mutation in the middle of the central disordered region of ETV6. …

    utswmed Repository record for Mechanisms of ETV6 Mislocalization in Familial Thrombocytopenia and Hematologic Malignancy (opens in a new tab)

  2. Assessing Patient Attitudes to ward Genetic Testing For Hereditary Hematologic Malignancy

    … have been identified to predispose to hereditary hematologic malignancy (HHM). Although the diagnostic yield of germline analysis for leukemia is similar to solid tumors, referral for genetic evaluation in adults with leukemia is underperformed. Identifying HHM is important for prognostication, …

    uthsc Repository record for Assessing Patient Attitudes to ward Genetic Testing For Hereditary Hematologic Malignancy (opens in a new tab)

  3. An Explanatory Model on Quality of Life in Patients with Hematologic Malignancy

    본 연구는 혈액암 환자의 삶의 질을 설명하는 요인을 규명하고 요인들 간의 영향력을 확인하여 설명모형을 제안함으로서 혈액암 환자의 삶의 질을 예측하는 요인을 제시하고자 시도되었다. 본 연구의 가설적 모형 구축을 위하여 Wilson과 Cleary (1995)의 건강관련 삶의 질 모델과 혈액암 환자의 삶의 질에 대한 선행연구를 분석한 결과, 자기효능감, 진단 후 기간, 사회적 지지는 외생변수로 증상, 자가간호행위, 지각된 건강상태, 삶의 질은 내생변수로 선정하였다. 자료 수집은 경기도 소재 2개 병원과 한국 혈액암 협회에서 치료 과정에 …

    ajou Repository record for An Explanatory Model on Quality of Life in Patients with Hematologic Malignancy (opens in a new tab) Embargoed until 9999-12-31

  4. Early empiric antibiotic therapy discontinuation in pediatric patients with hematologic malignancy and febrile neutropenia

    BACKGROUND: Infection is a major driver of morbidity and mortality in pediatric leukemia patients, who are highly susceptible to infections due to numerous risk factors associated with both the disease and its treatments. Febrile neutropenia, characterized by fever and an Absolute Neutrophil Count …

    bu Repository record for Early empiric antibiotic therapy discontinuation in pediatric patients with hematologic malignancy and febrile neutropenia (opens in a new tab)

  5. Chromosomal karyotype abnormalities are associated with increased risk of hematologic malignancies

    … utility in the diagnosis and treatment of hematologic malignancies, and may be predictive of risk of malignant transformation in individuals without apparent clinical presentation of a hematologic malignancy. To assess the association of large-scale chromosomal karyotype abnormalities and …

    washington Repository record for Chromosomal karyotype abnormalities are associated with increased risk of hematologic malignancies (opens in a new tab)

  6. Critical Illness in Patients with Hematologic Malignancies

    Introduction: Patients with hematologic malignancy are at increased risk of developing life-threatening complications that can lead to admission to an Intensive Care Unit (ICU). Acute respiratory failure is the most frequent reason for ICU admission in these patients. Existing knowledge gaps in the …

    toronto-retro Repository record for Critical Illness in Patients with Hematologic Malignancies (opens in a new tab)

  7. MODIFICATION BY PRE-EXISTING COMORBIDITIES OF THE EFFECT OF ADHERENCE TO A LUNG-PROTECTIVE MECHANICAL VENTILATION STRATEGY IN A COHORT OF PATIENTS WITH THE ACUTE RESPIRATORY DISTRESS SYNDROME

    … moderate or severe liver disease, 42 (8.7%) hematologic malignancy history, and 36 (7.4%) rheumatologic disease. The adjusted hazard ratio (HR) for mortality for each 12-hour period of LPV-ventilation was 0.96 (95% CI: 0.93-1.00; p=0.041). Only hematologic malignancy demonstrated a …

    jhu Repository record for MODIFICATION BY PRE-EXISTING COMORBIDITIES OF THE EFFECT OF ADHERENCE TO A LUNG-PROTECTIVE MECHANICAL VENTILATION STRATEGY IN A COHORT OF PATIENTS WITH THE ACUTE RESPIRATORY DISTRESS SYNDROME (opens in a new tab)

  8. The Regulation Of Myeloid Inflammatory Responses By Runx1: Roles In Normal And Malignant Hematopoiesis

    … mutated in sporadic and inherited forms of hematologic malignancies, but the mechanism underlying it role in leukemogenesis remains poorly defined. In the first part of this work, we describe a novel role for RUNX1 in regulating TLR1/2 and TLR4 signaling and inflammatory cytokine production …

    penn Repository record for The Regulation Of Myeloid Inflammatory Responses By Runx1: Roles In Normal And Malignant Hematopoiesis (opens in a new tab)

  9. Combining CAR T-Cell Therapy and Inhibitory Receptor Targeting for the Treatment of Acute Myeloid Leukemia

    Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with poor outcomes. Although CAR T-cell therapies have shown major clinical benefit in other cancers, their efficacy in AML has been limited by the lack of targets that can be safely engaged without causing myeloablation, and by …

    zurich

  10. Ex Vivo Expanded Cord Blood Natural Killer Cells As A Novel Therapeutic For Multiple Myeloma

    Multiple myeloma (MM) is the second most common hematologic malignancy in adults and, to date, is incurable. Allogeneic natural killer (NK) cells are active in various hematologic malignancies and may have a role against MM. Umbilical cord blood is a potential source for allogeneic NK cells and ex …

    uthsc Repository record for Ex Vivo Expanded Cord Blood Natural Killer Cells As A Novel Therapeutic For Multiple Myeloma (opens in a new tab)

  11. Production and development of a new immunotherapy targeting multiple myeloma

    Multiple myeloma (MM) is an incurable hematologic malignancy characterized by the accumulation of monoclonal plasma cells in the bone marrow. Although therapeutic strategies have significantly improved, relapse remains inevitable. Chimeric antigen receptor T-cell (CAR-T) therapy has demonstrated …

    liege Repository record for Production and development of a new immunotherapy targeting multiple myeloma (opens in a new tab) Embargoed

  12. Spectrum and Incidence of Primary and Therapy-Related Hematologic Malignancies In Individuals With Brca1 and Brca2 Pathogenic Variants

    … myeloid neoplasms (t-MN) are rare and deadly hematologic malignancies that develop following exposure to cytotoxic therapies such as radiation, chemotherapy, and poly (adenosine diphosphate-ribose)-ADP polymerase (PARP) inhibitors. Preliminary evidence suggests that germline BRCA1 and BRCA2 …

    uthsc Repository record for Spectrum and Incidence of Primary and Therapy-Related Hematologic Malignancies In Individuals With Brca1 and Brca2 Pathogenic Variants (opens in a new tab)

  13. Investigating the role of the bone marrow microenvironment in multiple myeloma

    Multiple myeloma (MM) is the second most common hematologic malignancy in the UK, characterised by uncontrolled plasma cell proliferation in the bone marrow (BM).Though the survival rate is improving, the MM incidence rate is increasing. Currently, MM is still incurable as with time malignant …

    east-anglia Download PDF for Investigating the role of the bone marrow microenvironment in multiple myeloma (opens in a new tab)

  14. Can early removal of central venous catheter influence duration of fever in febrile neutropenic patients with acute myeloid leukemia?

    … common and fatal problems to the patients with hematologic malignancy, especially acute leukemia. Additionally, febrile neutropenia costs a lot of money, because the patients generally need to be admitted to hospitals and treated by lots of medications like antibiotics and antifungal drugs. This …

    ajou Repository record for Can early removal of central venous catheter influence duration of fever in febrile neutropenic patients with acute myeloid leukemia? (opens in a new tab) Embargoed until 9999-12-31

  15. Comparison of FLT3 inhibitors with the standard treatment for FLT3-ITD mutated acute myeloid leukemia

    Acute myeloid leukemia (AML) is an aggressive hematologic malignancy, which is characterized by impaired differentiation and uncontrollable proliferation of myeloid progenitor cells in the bone marrow. One-third of patients with AML have a mutation in the FMS-like tyrosine kinase 3 (FLT3) gene. The …

    bu Repository record for Comparison of FLT3 inhibitors with the standard treatment for FLT3-ITD mutated acute myeloid leukemia (opens in a new tab)

  16. Αποτελεσματικότητα και ασφάλεια της αζαθειοπρίνης σε ασθενείς με ιδιοπαθή φλεγμονώδη νόσο των εντέρων στη Βορειοδυτική Ελλάδα

    … study was to investigate both the prevalence of malignancy development in IBD patients receiving AZA and the long-term safety of AZA and the management of adverse events.Methodology: Data were retrospectively extracted from the patient records of the Gastroenterology Department of the University …

    greece Repository record for Αποτελεσματικότητα και ασφάλεια της αζαθειοπρίνης σε ασθενείς με ιδιοπαθή φλεγμονώδη νόσο των εντέρων στη Βορειοδυτική Ελλάδα (opens in a new tab)

  17. Risk Factors Associated With Multiple Myeloma

    Multiple myeloma (MM) is a hematologic malignancy in which clonal plasma cells accumulate in the bone marrow, leading to the formation of lytic bone lesions, hypercalcemia, anemia, renal insufficiency, and immunosuppression. It develops from a pre-malignant condition known as monoclonal gammopathy …

    uab Repository record for Risk Factors Associated With Multiple Myeloma (opens in a new tab)

  18. Bone Marrow Adiposity, Obesity, And Tumor Burden In Newly Diagnosed Multiple Myeloma

    Multiple Myeloma (MM) is the second most common hematologic malignancy in the United States. It is characterized by the accumulation of clonally expanded plasma cells in the bone marrow, which leads to end organ damage and myeloma-defining events requiring treatment. The only modifiable risk factor …

    uab Repository record for Bone Marrow Adiposity, Obesity, And Tumor Burden In Newly Diagnosed Multiple Myeloma (opens in a new tab)

Page 1 of 4